Previous presentationNext presentation Oral presentation The EMCDDA 'Harm reduction initiative' to promote access to hepatitis testing and care Wednesday, 23 October, 2019 - 15:00 to 15:15Central square 1 (C1) Speakers PalczakKlaudia EMCDDA Presentation files 23 A2 1500 Klaudia Palczak .pdf1013.92 KBDownload Type Oral presentation Tracks The future of hepatitis C among people who inject drugs: new frontiers for policy, practice and science Keywords Infectious diseasesPublic health Part of session Enhancing the role of drug treatment services for HCV elimination among people who inject drugs